Recombinant Human LRATD2 Protein, N-His
Recombinant Human LRATD2 Protein, N-Hisexpressed in E. coli , spanning Asp75-His274. Purity: >90% by SDS-PAGE. Highlights His-Tagged: N-terminal 6xHis tag for IMAC purification. E. coli Expression: High-yield, cost-effective production. High Purity: >90% purity verified by SDS-PAGE.
Product Specifications
Product Name Alternative
Protein LRATD2, Breast cancer membrane protein 101, LRAT domain-containing 2, Protein FAM84B, Protein NSE2, LRATD2, BCMP101, FAM84B, NSE2
UniProt
Q96KN1
Expression Region
Asp75-His274
Origin
Homo sapiens (Human)
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Form
Lyophilized
Molecular Weight
25.30 kDa
Storage Conditions
-20°C
Notes
For research use only.
Tested Applications
ELISA, SDS-PAGE, WB
Preservative
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ABC-X0239 1 Vial
Xpress™ Human ARTN Over-expressing Stable Cell Line
Sign In for Pricing
View Details 
217263 25 mg
Cdc42/Rac1 GTPase Inhibitor, ML141 (MLS00693334, CID2950007, (±) -4- (4,5-Dihydro-5- (4-methoxyphenyl) -3-phenyl-1H-pyrazol-1-yl) -benzenesulfonamide, (±) -4- (5- (4-Methoxyphenyl) -3-phenyl-4,5-dihydro-1H-pyrazol-1-yl) ) -benzenesulfonamide, CDC42 GTPase Inhibitor II, CDC42 Inhibitor II, Rac1 Inhibitor V, Rac1 GTPase Inhibitor II)
Sign In for Pricing
View Details 